XM non fornisce servizi ai residenti degli Stati Uniti d'America.

Franco-US food M&A is $10 bln recipe for heartburn



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Franco-US food M&A is $10 bln recipe for heartburn</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Liam Proud

LONDON, Sept 26 (Reuters Breakingviews) -Two subscale companies in a low-margin, slow-growing sector might seem like ideal candidates for a deal. Not according to investors, who sent shares in $13 billion French catering group Sodexo EXHO.PA down 7% after Bloomberg reported that it was eyeing $10 billion U.S. rival Aramark ARMK.N. Recent iffy takeovers in the business-services sector show that scale isn’t always worth the risk.

Sodexo, which offers everything from food to cleaning services to corporate clients, didn’t comment on the news report. The company is effectively controlled by the family of deceased founder Pierre Bellon. Their vehicle, as of last August, had 43% of the shares and 58% of the voting rights. One practical question in any possible Aramark tie-up would be how to keep the Bellons in the driving seat of the enlarged group.

A cash takeover of the U.S. company would do the trick. But it would also risk a nasty debt hangover. The pair’s combined net debt, using their own definitions, is about $9 billion, or 3 times combined EBITDA over the past 12 months using Visible Alpha data. If Sodexo bought Aramark at a typical 30% premium in cash, implying a $13 billion equity value, the enlarged company would have a leverage ratio of 7 times trailing EBITDA before factoring in any cost synergies. That’s extremely high for a publicly listed company.

To keep debt below 4 times EBITDA after a deal, Sodexo would have to pay three-quarters in stock, according to Breakingviews calculations assuming the same 30% takeover premium. That, however, would reduce the Bellon vehicle’s economic ownership to 25% of the combined entity, and likely leave the family’s voting power below 50%. It’s also unclear whether U.S. investors would want to own Paris-listed shares in a larger group with quirky corporate governance.

An even bigger problem, potentially explaining Sodexo investors’ spooked reaction, is that the returns look low. At a 30% premium, the French group would be paying $18.2 billion for Aramark, including debt. The reward, by 2027, would be $900 million of net operating profit after tax, implying a miserable 5% return on invested capital, using analyst forecasts from Visible Alpha. To get the return above 8%, Aramark’s probable cost of capital, annual cost savings would have to exceed $750 million, equivalent to the U.S. company’s entire operating expenses this year, using analyst estimates.

Recent deals in the wider business-services sector, like Rentokil Initial’s RTO.L acquisition of Terminix and Teleperformance’s TEPRF.PA purchase of Majorel, have damaged the acquirer’s share prices. Big deals can lead to messy integrations and heavy debt loads, absorbing resources that might otherwise have gone towards boosting growth. Little wonder Sodexo’s shareholders are finding the news hard to stomach.

Follow @Breakingviews on X


CONTEXT NEWS

Sodexo is exploring a potential acquisition of its U.S. rival Aramark, Bloomberg reported on Sept. 25 citing people familiar with the matter.

Sodexo has been periodically discussing the deal with food and facilities management provider Aramark in recent months, the report said.

Contacted by Reuters, Aramark and Sodexo declined to comment on the report.

Shares in Sodexo were down 7.4% to 72.95 euros as of 0850 GMT on Sept. 26.


Graphic: Investors fret about business-services M&A https://reut.rs/3BmYtPZ


Editing by Neil Unmack and Oliver Taslic

</body></html>

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Avvertenza sul rischio: Il tuo capitale è a rischio. I prodotti con leva finanziaria possono non essere adatti a tutti. Ti chiediamo di consultare attentamente la nostra Informativa sul rischio.